How big is the human immunodeficiency virus hiv1 therapeutics market?

The human immunodeficiency virus HIV is a lentivirus a subgroup of retrovirus that causes HIV infection and over time acquired immunodeficiency syndrome AIDS.AIDS is a condition in humans in which progressive failure of the immune system allows lifethreatening opportunistic infections and cancers to thrive.The key factors responsible for driving the market growth include the increasing incidence of HIV infections especially amongst the youth due to unprotected sexual practices exposure to needles or syringes contaminated with infected body fluids or tissues lack of awareness regarding transmission risk factors etc.Market Analysis and Insights Global Human Immunodeficiency Virus HIV1 Therapeutics MarketThe global Human Immunodeficiency Virus HIV1 Therapeutics market size is projected to reach US 12560 million by 2027 from US 11880 million in 2020 at a CAGR of 0.8 during 20212027.With industry.

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Insights, Forecast to 2028

Q: Who are the key players in the human immunodeficiency virus hiv1 therapeutics market?

Some of the key players are ViiV Healthcare, Mylan NV, AbbVie, Merck& Co. Inc, Bristol Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech Inc, Cipla Ltd, Boehringer Ingelheim GmbH, Genentech Inc, Others.

Code: QYRE-Auto-28E5708

Report

March 2022

Pages:105

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Bristol Myers Squibb Company

Boehringer Ingelheim GmbH

Genentech Inc

Cipla Ltd

AbbVie Inc. (U.S.)

Merck & Co., Inc. (U.S.)

Bristol-Myers Squibb Company (U.S.)

Boehringer Ingelheim GmbH (Germany)

Genentech, Inc. (U.S.)

Cipla, Inc. (India)

Market Analysis and Insights: Global Human Immunodeficiency Virus (HIV) Therapeutics Market

The global Human Immunodeficiency Virus (HIV) Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, NRTIs accounting for % of the Human Immunodeficiency Virus (HIV) Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Human Immunodeficiency Virus (HIV) Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Human Immunodeficiency Virus (HIV) Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Human Immunodeficiency Virus (HIV) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Immunodeficiency Virus (HIV) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Immunodeficiency Virus (HIV) Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Immunodeficiency Virus (HIV) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Immunodeficiency Virus (HIV) Therapeutics market.

Global Human Immunodeficiency Virus (HIV) Therapeutics Scope and Market Size

Human Immunodeficiency Virus (HIV) Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Human Immunodeficiency Virus (HIV) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

NRTIs

NNRTIs

Entry and Fusion Inhibitors

Protease Inhibitors

Integrase Inhibitors

Coreceptor Antagonists

Segment by Application

Hospitals

Clinics

Labs

BY COMPANY

ViiV Healthcare

Mylan

AbbVie

Merck & Co., Inc.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Genentech, Inc.

Cipla, Inc.

Boehringer Ingelheim GmbH

Genentech, Inc.

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Bristol Myers Squibb Company

Boehringer Ingelheim GmbH

Genentech Inc

Cipla Ltd

AbbVie Inc. (U.S.)

Merck & Co., Inc. (U.S.)

Bristol-Myers Squibb Company (U.S.)

Boehringer Ingelheim GmbH (Germany)

Genentech, Inc. (U.S.)

Cipla, Inc. (India)

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 NRTIs

1.2.3 NNRTIs

1.2.4 Entry and Fusion Inhibitors

1.2.5 Protease Inhibitors

1.2.6 Integrase Inhibitors

1.2.7 Coreceptor Antagonists

1.3 Market by Application

1.3.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Labs

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Perspective (2017-2028)

2.2 Human Immunodeficiency Virus (HIV) Therapeutics Growth Trends by Region

2.2.1 Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Dynamics

2.3.1 Human Immunodeficiency Virus (HIV) Therapeutics Industry Trends

2.3.2 Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers

2.3.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges

2.3.4 Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue

3.1.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue (2017-2022)

3.1.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Therapeutics Revenue

3.4 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio

3.4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2021

3.5 Human Immunodeficiency Virus (HIV) Therapeutics Key Players Head office and Area Served

3.6 Key Players Human Immunodeficiency Virus (HIV) Therapeutics Product Solution and Service

3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Type

4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2023-2028)

5 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Application

5.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2017-2028)

6.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type

6.2.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022)

6.2.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028)

6.2.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2017-2028)

6.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application

6.3.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022)

6.3.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028)

6.3.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2017-2028)

6.4 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country

6.4.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022)

6.4.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2017-2028)

7.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type

7.2.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022)

7.2.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028)

7.2.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2017-2028)

7.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application

7.3.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022)

7.3.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028)

7.3.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2017-2028)

7.4 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country

7.4.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022)

7.4.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type

8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2017-2028)

8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application

8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2017-2028)

8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region

8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2017-2028)

9.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type

9.2.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022)

9.2.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028)

9.2.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2017-2028)

9.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application

9.3.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022)

9.3.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028)

9.3.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2017-2028)

9.4 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country

9.4.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022)

9.4.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type

10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2017-2028)

10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application

10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2017-2028)

10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country

10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 ViiV Healthcare

11.1.1 ViiV Healthcare Company Details

11.1.2 ViiV Healthcare Business Overview

11.1.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.1.4 ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.1.5 ViiV Healthcare Recent Developments

11.2 Mylan

11.2.1 Mylan Company Details

11.2.2 Mylan Business Overview

11.2.3 Mylan Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.2.4 Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.2.5 Mylan Recent Developments

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.3.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.3.5 AbbVie Recent Developments

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Details

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.4.4 Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.4.5 Merck & Co., Inc. Recent Developments

11.5 Bristol-Myers Squibb Company

11.5.1 Bristol-Myers Squibb Company Company Details

11.5.2 Bristol-Myers Squibb Company Business Overview

11.5.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.5.4 Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.5.5 Bristol-Myers Squibb Company Recent Developments

11.6 Boehringer Ingelheim GmbH

11.6.1 Boehringer Ingelheim GmbH Company Details

11.6.2 Boehringer Ingelheim GmbH Business Overview

11.6.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.6.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.6.5 Boehringer Ingelheim GmbH Recent Developments

11.7 Genentech, Inc.

11.7.1 Genentech, Inc. Company Details

11.7.2 Genentech, Inc. Business Overview

11.7.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.7.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.7.5 Genentech, Inc. Recent Developments

11.8 Cipla, Inc.

11.8.1 Cipla, Inc. Company Details

11.8.2 Cipla, Inc. Business Overview

11.8.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.8.4 Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.8.5 Cipla, Inc. Recent Developments

11.9 Boehringer Ingelheim GmbH

11.9.1 Boehringer Ingelheim GmbH Company Details

11.9.2 Boehringer Ingelheim GmbH Business Overview

11.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.9.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.9.5 Boehringer Ingelheim GmbH Recent Developments

11.10 Genentech, Inc.

11.10.1 Genentech, Inc. Company Details

11.10.2 Genentech, Inc. Business Overview

11.10.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.10.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

11.10.5 Genentech, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol Myers Squibb Company

Boehringer Ingelheim GmbH

Genentech Inc

Cipla Ltd

AbbVie Inc. (U.S.)

Merck & Co., Inc. (U.S.)

Bristol-Myers Squibb Company (U.S.)

Boehringer Ingelheim GmbH (Germany)

Genentech, Inc. (U.S.)

Cipla, Inc. (India)

List of Tables

Table 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of NRTIs

Table 3. Key Players of NNRTIs

Table 4. Key Players of Entry and Fusion Inhibitors

Table 5. Key Players of Protease Inhibitors

Table 6. Key Players of Integrase Inhibitors

Table 7. Key Players of Coreceptor Antagonists

Table 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 11. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2017-2022)

Table 12. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2023-2028)

Table 14. Human Immunodeficiency Virus (HIV) Therapeutics Market Trends

Table 15. Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers

Table 16. Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges

Table 17. Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

Table 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue by Players (2017-2022) & (US$ Million)

Table 19. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Share by Players (2017-2022)

Table 20. Global Top Human Immunodeficiency Virus (HIV) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2021)

Table 21. Ranking of Global Top Human Immunodeficiency Virus (HIV) Therapeutics Companies by Revenue (US$ Million) in 2021

Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue (CR5 and HHI) & (2017-2022)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Human Immunodeficiency Virus (HIV) Therapeutics Product Solution and Service

Table 25. Date of Enter into Human Immunodeficiency Virus (HIV) Therapeutics Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 28. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2017-2022)

Table 29. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 30. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2023-2028)

Table 31. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 32. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Share by Application (2017-2022)

Table 33. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 34. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Share by Application (2023-2028)

Table 35. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 36. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 37. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 38. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 39. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 40. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 41. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 42. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 43. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 44. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 45. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 46. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 47. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 48. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 49. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 50. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 51. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 52. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2023-2028) & (US$ Million)

Table 53. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 54. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 55. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 56. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 57. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 58. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 63. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 64. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 65. ViiV Healthcare Company Details

Table 66. ViiV Healthcare Business Overview

Table 67. ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 68. ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 69. ViiV Healthcare Recent Developments

Table 70. Mylan Company Details

Table 71. Mylan Business Overview

Table 72. Mylan Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 73. Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 74. Mylan Recent Developments

Table 75. AbbVie Company Details

Table 76. AbbVie Business Overview

Table 77. AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 78. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 79. AbbVie Recent Developments

Table 80. Merck & Co., Inc. Company Details

Table 81. Merck & Co., Inc. Business Overview

Table 82. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 83. Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 84. Merck & Co., Inc. Recent Developments

Table 85. Bristol-Myers Squibb Company Company Details

Table 86. Bristol-Myers Squibb Company Business Overview

Table 87. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 88. Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 89. Bristol-Myers Squibb Company Recent Developments

Table 90. Boehringer Ingelheim GmbH Company Details

Table 91. Boehringer Ingelheim GmbH Business Overview

Table 92. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 93. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 94. Boehringer Ingelheim GmbH Recent Developments

Table 95. Genentech, Inc. Company Details

Table 96. Genentech, Inc. Business Overview

Table 97. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 98. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 99. Genentech, Inc. Recent Developments

Table 100. Cipla, Inc. Company Details

Table 101. Cipla, Inc. Business Overview

Table 102. Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 103. Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 104. Cipla, Inc. Recent Developments

Table 105. Boehringer Ingelheim GmbH Company Details

Table 106. Boehringer Ingelheim GmbH Business Overview

Table 107. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 108. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 109. Boehringer Ingelheim GmbH Recent Developments

Table 110. Genentech, Inc. Company Details

Table 111. Genentech, Inc. Business Overview

Table 112. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 113. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022) & (US$ Million)

Table 114. Genentech, Inc. Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type: 2021 VS 2028

Figure 2. NRTIs Features

Figure 3. NNRTIs Features

Figure 4. Entry and Fusion Inhibitors Features

Figure 5. Protease Inhibitors Features

Figure 6. Integrase Inhibitors Features

Figure 7. Coreceptor Antagonists Features

Figure 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application: 2021 VS 2028

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Labs Case Studies

Figure 12. Human Immunodeficiency Virus (HIV) Therapeutics Report Years Considered

Figure 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 14. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 15. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region: 2021 VS 2028

Figure 16. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players in 2021

Figure 17. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2021)

Figure 18. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2021

Figure 19. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 20. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Type (2017-2028)

Figure 21. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Application (2017-2028)

Figure 22. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Share by Country (2017-2028)

Figure 23. United States Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Canada Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 26. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Type (2017-2028)

Figure 27. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Application (2017-2028)

Figure 28. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size Share by Country (2017-2028)

Figure 29. Germany Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. France Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. U.K. Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Italy Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Russia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Nordic Countries Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 36. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Type (2017-2028)

Figure 37. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Application (2017-2028)

Figure 38. Asia Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size Share by Region (2017-2028)

Figure 39. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Japan Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. South Korea Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Southeast Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. India Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. Australia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 45. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 46. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Type (2017-2028)

Figure 47. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Application (2017-2028)

Figure 48. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Share by Country (2017-2028)

Figure 49. Mexico Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Brazil Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 51. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 52. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Type (2017-2028)

Figure 53. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size Market Share by Application (2017-2028)

Figure 54. Middle East and Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size Share by Country (2017-2028)

Figure 55. Turkey Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Saudi Arabia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. UAE Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 58. ViiV Healthcare Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 59. Mylan Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 60. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 61. Merck & Co., Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 63. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 64. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 65. Cipla, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 66. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 67. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2017-2022)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Insights, Forecast to 2028

Published Date: March 2022

Report Code: QYRE-Auto-28E5708

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions